{"symbol":"LLY","fiscalQuarter":"Q4-2009","reportDate":"2010-01-28","reportTime":"BMO","status":"reported","company":{"name":"Eli Lilly and Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/LLY/earnings/Q4-2009","postBrief":{"headline":"Eli Lilly Misses on EPS, Stock Down 1.76%","keyNumbers":[{"metric":"EPS","actual":"$0.83","expected":"N/A","surprise":"-10.27%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Eli Lilly's earnings report shows a miss on EPS, which contributed to a stock decline of 1.76%. Investors may be concerned about the company's performance given the lack of revenue data and guidance. The negative surprise in EPS could lead to increased scrutiny from analysts and investors moving forward.","metaDescription":"Eli Lilly (LLY) Q4 2009 earnings: EPS missed expectations. Stock down 1.76%. Full breakdown."}}